Assessing Fibrosis and Steatosis utilizing Transient Elastography (Fibroscan) in Metabolic-dysfunction Associated Steatotic Liver Disease: An Experience from UBTH, Benin City, Nigeria.
The study highlighted a 6.4% MASLD prevalence, with central obesity, BMI, and comorbidity identified as independent risk factors. Fibroscan revealed 12% of MASLD patients had significant fibrosis with obesity and higher WHR as risk factors.
Authors
- RA Ugiagbe
- Abraham O. Malu
- E E Ugiagbe
Institutions
- Benue State University (NG)
- University of Benin Teaching Hospital (NG)
- University of Benin (NG)
Publication Details
- Journal
- PubMed
- Published
- 2025-02-28
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00